P3 Health Partners Inc. (PIII): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$186.14M
Year ended 2025-12-31
-$64.48M
Trailing 12 months to 2026-06-30
2019-12-31: -$39.14M2020-12-31: -$27.79M2022-12-31: -$1.47B2023-12-31: -$81.25M2024-12-31: -$234.60M2025-12-31: -$186.14M-$186.14M
2019-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$186.14Mn/m2026-03-26, From 2025-01-01
2024-12-31-$234.60Mn/m2026-03-26, From 2024-01-01
2023-12-31-$81.25Mn/m2025-03-28, From 2023-01-01
2022-12-31-$1.47Bn/a2024-03-28, From 2022-01-01
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31-$27.79Mn/m2022-10-21, From 2020-01-01
2019-12-31-$39.14Mn/a2022-10-21, From 2019-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
P3 Health Partners Inc. (PIII)2025-12-31-$186.14Mn/m
LifeStance Health Group, Inc. (LFST)2025-12-31$65.77M+625.6%
Privia Health Group, Inc. (PRVA)2025-12-31$44.14M+82.0%
InnovAge Holding Corp. (INNV)2026-06-30$23.76Mn/m
Pennant Group, Inc. (PNTG)2025-12-31$60.42M+36.6%
U S Physical Therapy Inc (USPH)2025-12-31$109.07M+33.5%
GeneDx Holdings Corp. (WGS)2025-12-31-$3.48Mn/m
DocGo Inc. (DCGO)2025-12-31-$162.37Mn/m
Omada Health, Inc. (OMDA)2025-12-31-$6.48Mn/m

Compare PIII, LFST, PRVA, INNV side by side · Screen every company in Services-Health Services ↗